374 related articles for article (PubMed ID: 21702008)
1. Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus.
Nielsen CT; Østergaard O; Johnsen C; Jacobsen S; Heegaard NH
Arthritis Rheum; 2011 Oct; 63(10):3067-77. PubMed ID: 21702008
[TBL] [Abstract][Full Text] [Related]
2. A heparin-based method for flow cytometric analysis of microparticles directly from platelet-poor plasma in calcium containing buffer.
Iversen LV; Ostergaard O; Nielsen CT; Jacobsen S; Heegaard NH
J Immunol Methods; 2013 Feb; 388(1-2):49-59. PubMed ID: 23246793
[TBL] [Abstract][Full Text] [Related]
3. Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis.
Iversen LV; Østergaard O; Ullman S; Nielsen CT; Halberg P; Karlsmark T; Heegaard NH; Jacobsen S
Scand J Rheumatol; 2013; 42(6):473-82. PubMed ID: 24016306
[TBL] [Abstract][Full Text] [Related]
4. Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation.
Nielsen CT; Østergaard O; Stener L; Iversen LV; Truedsson L; Gullstrand B; Jacobsen S; Heegaard NH
Arthritis Rheum; 2012 Apr; 64(4):1227-36. PubMed ID: 22238051
[TBL] [Abstract][Full Text] [Related]
5. Circulating microparticles in systemic Lupus Erythematosus.
Nielsen CT
Dan Med J; 2012 Nov; 59(11):B4548. PubMed ID: 23171755
[TBL] [Abstract][Full Text] [Related]
6. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state.
Pereira J; Alfaro G; Goycoolea M; Quiroga T; Ocqueteau M; Massardo L; Pérez C; Sáez C; Panes O; Matus V; Mezzano D
Thromb Haemost; 2006 Jan; 95(1):94-9. PubMed ID: 16543967
[TBL] [Abstract][Full Text] [Related]
7. Circulating microparticle subpopulations in systemic lupus erythematosus are affected by disease activity.
López P; Rodríguez-Carrio J; Martínez-Zapico A; Caminal-Montero L; Suárez A
Int J Cardiol; 2017 Jun; 236():138-144. PubMed ID: 28279502
[TBL] [Abstract][Full Text] [Related]
8. Microparticles in the blood of patients with systemic lupus erythematosus (SLE): phenotypic characterization and clinical associations.
Mobarrez F; Vikerfors A; Gustafsson JT; Gunnarsson I; Zickert A; Larsson A; Pisetsky DS; Wallén H; Svenungsson E
Sci Rep; 2016 Oct; 6():36025. PubMed ID: 27777414
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity.
Sellam J; Proulle V; Jüngel A; Ittah M; Miceli Richard C; Gottenberg JE; Toti F; Benessiano J; Gay S; Freyssinet JM; Mariette X
Arthritis Res Ther; 2009; 11(5):R156. PubMed ID: 19832990
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of microparticles in whole blood by multicolour flow cytometry assay.
Christersson C; Johnell M; Siegbahn A
Scand J Clin Lab Invest; 2013 Apr; 73(3):229-39. PubMed ID: 23452203
[TBL] [Abstract][Full Text] [Related]
11. Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus--a possible link to venous thrombosis?
Lood C; Eriksson S; Gullstrand B; Jönsen A; Sturfelt G; Truedsson L; Bengtsson AA
Lupus; 2012 Nov; 21(13):1423-32. PubMed ID: 22878256
[TBL] [Abstract][Full Text] [Related]
12. Platelet C4d is highly specific for systemic lupus erythematosus.
Navratil JS; Manzi S; Kao AH; Krishnaswami S; Liu CC; Ruffing MJ; Shaw PS; Nilson AC; Dryden ER; Johnson JJ; Ahearn JM
Arthritis Rheum; 2006 Feb; 54(2):670-4. PubMed ID: 16447243
[TBL] [Abstract][Full Text] [Related]
13. Unique protein signature of circulating microparticles in systemic lupus erythematosus.
Østergaard O; Nielsen CT; Iversen LV; Tanassi JT; Knudsen S; Jacobsen S; Heegaard NH
Arthritis Rheum; 2013 Oct; 65(10):2680-90. PubMed ID: 23817959
[TBL] [Abstract][Full Text] [Related]
14. Potential Involvement of Platelet-Derived Microparticles and Microparticles Forming Immune Complexes during Monocyte Activation in Patients with Systemic Lupus Erythematosus.
Burbano C; Villar-Vesga J; Orejuela J; Muñoz C; Vanegas A; Vásquez G; Rojas M; Castaño D
Front Immunol; 2018; 9():322. PubMed ID: 29545790
[TBL] [Abstract][Full Text] [Related]
15. Increased circulating CD31+/annexin V+ apoptotic microparticles and decreased circulating endothelial progenitor cell levels in hypertensive patients with microalbuminuria.
Huang PH; Huang SS; Chen YH; Lin CP; Chiang KH; Chen JS; Tsai HY; Lin FY; Chen JW; Lin SJ
J Hypertens; 2010 Aug; 28(8):1655-65. PubMed ID: 20520578
[TBL] [Abstract][Full Text] [Related]
16. An innovative flow cytometric approach for small-size platelet microparticles: influence of calcium.
Montoro-García S; Shantsila E; Orenes-Piñero E; Lozano ML; Lip GY
Thromb Haemost; 2012 Aug; 108(2):373-83. PubMed ID: 22740162
[TBL] [Abstract][Full Text] [Related]
17. Urinary podocyte microparticles are associated with disease activity and renal injury in systemic lupus erythematosus.
Lu J; Hu ZB; Chen PP; Lu CC; Zhang JX; Li XQ; Yuan BY; Huang SJ; Ma KL
BMC Nephrol; 2019 Aug; 20(1):303. PubMed ID: 31382919
[TBL] [Abstract][Full Text] [Related]
18. [Impacts of microparticles on vascular endothelial cells].
Wei Y; Wu ZH; Qiu GX; Gao CJ; Weng XS
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(11):754-9. PubMed ID: 18683684
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of selected endothelial activation markers in patients with systemic lupus erythematosus.
Kuryliszyn-Moskal A; Klimiuk PA; Ciolkiewicz M; Sierakowski S
J Rheumatol; 2008 Jul; 35(7):1307-13. PubMed ID: 18484695
[TBL] [Abstract][Full Text] [Related]
20. Number of microparticles generated during acute myocardial infarction and stable angina correlates with platelet activation.
Stępień E; Stankiewicz E; Zalewski J; Godlewski J; Zmudka K; Wybrańska I
Arch Med Res; 2012 Jan; 43(1):31-5. PubMed ID: 22306248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
